Tag Archives: Johnson

Johnson & Johnson snares FDA nod for first exon 20-targeted drug in EGFR lung cancer

Just a few short months after Johnson & Johnson’s Janssen unit sent its targeted non-small cell lung cancer drug amivantamab to the FDA, the regulator has come back with a green light—a very specific one. Now christened Rybrevant, the drug is the first-ever treatment for non-small cell lung cancer with a group of epidermal growth factor receptor (EGFR) mutations found in… Read More »

Johnson & Johnson’s COVID-19 vaccine wins renewed backing from U.S. experts after probe into rare blood clots

After officials halted Johnson & Johnson’s COVID-19 vaccine rollout in its tracks last week, U.S. vaccine advisers agreed on Friday that vaccinations should resume. Going forward, the shot will carry a warning about rare and severe blood clots, they said. Of the nearly 8 million doses administered, officials identified 15 cases of thrombosis with thrombocytopenia (TTS), CDC vaccine advisers said Friday. Three vaccine recipients who developed TTS have died. All… Read More »

Dr Hilary issues latest advice on Johnson & Johnson as UK has batches to offer Brits

The NHS made a point that the “extremely rare blood clotting problem” only affects “a small number of people who have had the Oxford/AstraZeneca vaccine”. “For people aged 30 and over, and those with other health conditions, the benefits of being vaccinated outweighs any risk of clotting problems,” said the NHS. Those under the age… Read More »